Literature DB >> 10194069

Differential tumor necrosis factor alpha production in simian immunodeficiency virus-infected rhesus macaques coinfected with Mycobacterium avium.

G W Newman1, D L Adams, J N Maslow, M Murphy-Corb, P J Didier.   

Abstract

Mycobacterium avium infections are the third most common opportunistic infection in patients with AIDS. Simian immunodeficiency virus (SIV)-infected rhesus macaques naturally acquire M. avium infections from the environment, and their clinical symptoms are similar to those observed in AIDS patients. We characterized concurrent infection with SIV and M. avium in monkeys on the basis of the growth of the bacteria in macrophages (Mphis) from rhesus macaques and the ability of M. avium to induce SIV replication and tumor necrosis factor alpha (TNF-alpha) production. The simian M. avium isolate grew significantly better than did an isolate from an AIDS patient or a chicken isolate (P = .001); it induced significantly more TNF-alpha production in Mphis from SIV-positive and SIV-negative monkeys than did the isolate from an AIDS patient (P = .013). No significant increase in SIV replication was seen in the M. avium isolates, and no correlation was found between increased SIV replication and increased TNF-alpha production. In addition, Mphis from monkeys infected with M. avium during late-stage SIV disease produced less TNF-alpha when stimulated with virulent M. avium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194069     DOI: 10.1086/515166

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

Review 1.  Animal models to study Mycobacterium tuberculosis and HIV co-infection.

Authors:  Ming Guo; Wen-Zhe Ho
Journal:  Dongwuxue Yanjiu       Date:  2014-05

2.  Single nucleotide polymorphisms within the promoter region of the rhesus monkey tumor necrosis factor-alpha gene.

Authors:  Krishna K Singh; Jörg Schmidtke
Journal:  Immunogenetics       Date:  2005-04-20       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.